Perigon Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Perigon Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,193	Closed	-$222K	–	638
2022 Q1	$222K	Hold	54,193	–	–	0.02%	558
2021 Q4	$193K	Hold	54,193	–	–	0.01%	560
2021 Q3	$197K	Buy	54,193 +30,220	+126%	+$122K	0.02%	518
2021 Q2	$105K	Hold	23,973	–	–	0.01%	510
2021 Q1	$99K	Hold	23,973	–	–	0.01%	485
2020 Q4	$96K	Hold	23,973	–	–	0.01%	549
2020 Q3	$65K	Sell	23,973 -362	-1%	-$1K	0.01%	379
2020 Q2	$67K	Buy	+24,335	New	+$67.9K	0.01%	353

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Perigon Wealth Management's ATRS Position: Q2 2022 in Review

Perigon Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 54,193 shares — an estimated $222K sold.

Perigon Wealth Management first reported a position in ATRS in Q2 2020 and held it in 8 quarters. The position peaked at $222K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Perigon Wealth Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Perigon Wealth Management sold 54,193 Antares Pharma, Inc. shares in Q2 2022, an estimated $222K.
Perigon Wealth Management first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 8 quarters.
Perigon Wealth Management's Antares Pharma, Inc. position peaked at $222K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Perigon Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.